Financhill
Back

Apogee Therapeutics Stock Predictions

Apogee Therapeutics Stock Forecast

  • Is Apogee Therapeutics Stock Undervalued?
    The current Apogee Therapeutics [APGE] share price is $44.50. The Score for APGE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Apogee Therapeutics Stock Go Up Next Year?

Data Unavailable

Apogee Therapeutics Stock Rating

Data Unavailable

Apogee Therapeutics Stock Price History

Is APGE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apogeetherapeutics.com

52-Week Data

52-Week High:
72.29
52-Week Low:
22.11

Prediction Charts

Market Cap:
2.53B
Price in USD:
44.50
Volume:
686.74K
Beta:
2.44

Technical Analysis

SMA50:
51.62
SMA100:
50.57
SMA200:
50.76
52-Wk Change:
101.08%

Stock Predictions

  • Is Apogee Therapeutics stock public?
    Yes, Apogee Therapeutics is a publicly traded company.
  • What is the Apogee Therapeutics stock quote today?
    The Apogee Therapeutics stock price is 44.50 USD today.
  • How to buy Apogee Therapeutics stock online?
    You can buy Apogee Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 45.51 43.85 45.99 42.52
Nov-26 44.11 43.96 44.43 43.13
Nov-27 45.08 44.70 45.40 43.90
Nov-29 44.74 45.15 45.73 44.09
Dec-2 45.75 46.14 48.14 45.15
Dec-3 46.42 46.26 47.50 45.16
Dec-4 46.07 52.02 53.62 45.69
Dec-5 51.48 47.16 52.92 46.62
Dec-6 47.31 49.97 50.48 47.31
Dec-9 49.84 49.07 51.39 48.39
Dec-10 49.34 48.38 49.63 47.95
Dec-11 48.62 48.77 50.90 47.74
Dec-12 48.77 44.32 50.36 43.82
Dec-13 44.14 44.50 45.32 41.85

Apogee Therapeutics Earnings

Data Unavailable

Apogee Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.97 per share.

* Apogee Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.